The Centralized List annual renewal application and fee must be submitted to DOJ by January 31st of each year regardless of the date of initial placement on the Centralized List. The Centralized List portion of the annual fee is $20.00 per licensee at each dealership.
Hydrocodone Bitartrate, USP 7.5 mg. Ibuprofen, USP 200 mg. VICOPROFEN (hydrocodone and ibuprofen) is supplied in a fixed combination tablet form for oral administration. VICOPROFEN (hydrocodone and ibuprofen) combines the opioid analgesic agent, hydrocodone bitartrate, with the nonsteroidal anti-inflammatory (NSAID) agent, ibuprofen.
For those of you who may have missed it, the Drug Enforcement Administration (DEA) has officially scheduled tramadol as a Schedule IV substance within the U.S. under the Controlled Substance Act, which will be effective as of August 18 of this year. The legislation has been in the works by the DEA for over a year now.